# A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body

> **NCT03654170** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 6 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 425809 mixed with [C-14] BI425809

## Key facts

- **NCT ID:** NCT03654170
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-11
- **Primary completion:** 2018-11-12
- **Final completion:** 2018-11-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654170, "A Study in Healthy Men to Find Out How BI 425809 is Taken up and Handled by the Body". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03654170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*